The germinal centre B cell response to SARS-CoV-2

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The germinal center (GC) response is essential for generating long-lasting protective immunity through affinity-matured plasma and memory B cells.
• Understanding the GC response to SARS-CoV-2 infection and vaccination is critical for assessing B cell-mediated protection.
• Directly assessing the human GC response presents significant challenges.

Purpose of the Study:

• To review the evidence supporting the role of the GC response in durable and broad immunity against SARS-CoV-2.
• To explore novel strategies for modulating the GC response to enhance protection against emerging SARS-CoV-2 variants.
• To present findings on the persistence of the GC B cell response following SARS-CoV-2 mRNA vaccination.

Main Methods:

• Review of emerging scientific literature on GC responses in SARS-CoV-2 infection and vaccination.
• Analysis of data on the duration of GC B cell responses in lymph nodes post-vaccination.
• Discussion of potential therapeutic and prophylactic approaches targeting GC modulation.

Main Results:

• Emerging evidence highlights the importance of the GC response for robust and enduring immunity against SARS-CoV-2.
• The GC B cell response has been observed to persist in draining lymph nodes for at least six months after mRNA vaccination in some individuals.
• New strategies for modulating the GC response are being developed to improve protection against SARS-CoV-2 variants.

Conclusions:

• The GC response plays a pivotal role in establishing protective immunity against SARS-CoV-2.
• Persistent GC B cell responses post-vaccination suggest a durable immunological memory.
• Modulating the GC response holds promise for enhancing vaccine efficacy and combating viral evolution.